File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)

Article: Enhancing the efficacy of vaccinia-based oncolytic virotherapy by inhibiting CXCR2-mediated MDSC trafficking

TitleEnhancing the efficacy of vaccinia-based oncolytic virotherapy by inhibiting CXCR2-mediated MDSC trafficking
Authors
Issue Date8-Dec-2023
PublisherOxford University Press
Citation
Journal of Leukocyte Biology, 2023 How to Cite?
Abstract

Oncolytic virotherapy is an innovative approach for cancer treatment. However, recruitment of myeloid derived suppressor cells (MDSC) into the tumor microenvironment (TME) after oncolysis-mediated local inflammation leads to tumor resistance to the therapy. Using the murine malignant mesothelioma model, we demonstrated that the in-situ vaccinia virotherapy recruited primarily polymorphonuclear MDSC (PMN-MDSC) into the TME where they exhibited strong suppression of cytotoxic T lymphocytes (CTL) in a reactive oxygen species (ROS)-dependent way. Single-cell RNA sequencing analysis confirmed the suppressive profile of PMN-MDSC at the transcriptomic level and identified CXCR2 as a therapeutic target expressed on PMN-MDSC. Abrogating PMN-MDSC trafficking by CXCR2-specific small molecule inhibitor during the vaccinia virotherapy exhibited enhanced antitumor efficacy in three syngeneic cancer models, through increasing CD8+/MDSC ratios in the TME, activating CTL and skewing suppressive TME into an antitumor environment. Our results warrant clinical development of CXCR2 inhibitor in combination with oncolytic virotherapy.


Persistent Identifierhttp://hdl.handle.net/10722/340987
ISSN
2023 Impact Factor: 3.6
2023 SCImago Journal Rankings: 1.521

 

DC FieldValueLanguage
dc.contributor.authorTan, Zhiwu-
dc.contributor.authorChiu, Mei Sum-
dc.contributor.authorYue, Ming-
dc.contributor.authorKwok, Hau Yee-
dc.contributor.authorTse, Man Ho-
dc.contributor.authorWen, Yang-
dc.contributor.authorChen, Bohao-
dc.contributor.authorYang, Dawei-
dc.contributor.authorZhou, Dongyan-
dc.contributor.authorSong, You-Qiang-
dc.contributor.authorMan, Kwan-
dc.contributor.authorChen, Zhiwei-
dc.date.accessioned2024-03-11T10:48:49Z-
dc.date.available2024-03-11T10:48:49Z-
dc.date.issued2023-12-08-
dc.identifier.citationJournal of Leukocyte Biology, 2023-
dc.identifier.issn0741-5400-
dc.identifier.urihttp://hdl.handle.net/10722/340987-
dc.description.abstract<p>Oncolytic virotherapy is an innovative approach for cancer treatment. However, recruitment of myeloid derived suppressor cells (MDSC) into the tumor microenvironment (TME) after oncolysis-mediated local inflammation leads to tumor resistance to the therapy. Using the murine malignant mesothelioma model, we demonstrated that the in-situ vaccinia virotherapy recruited primarily polymorphonuclear MDSC (PMN-MDSC) into the TME where they exhibited strong suppression of cytotoxic T lymphocytes (CTL) in a reactive oxygen species (ROS)-dependent way. Single-cell RNA sequencing analysis confirmed the suppressive profile of PMN-MDSC at the transcriptomic level and identified CXCR2 as a therapeutic target expressed on PMN-MDSC. Abrogating PMN-MDSC trafficking by CXCR2-specific small molecule inhibitor during the vaccinia virotherapy exhibited enhanced antitumor efficacy in three syngeneic cancer models, through increasing CD8+/MDSC ratios in the TME, activating CTL and skewing suppressive TME into an antitumor environment. Our results warrant clinical development of CXCR2 inhibitor in combination with oncolytic virotherapy.</p>-
dc.languageeng-
dc.publisherOxford University Press-
dc.relation.ispartofJournal of Leukocyte Biology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleEnhancing the efficacy of vaccinia-based oncolytic virotherapy by inhibiting CXCR2-mediated MDSC trafficking-
dc.typeArticle-
dc.identifier.doi10.1093/jleuko/qiad150-
dc.identifier.eissn1938-3673-
dc.identifier.issnl0741-5400-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats